
Hot Picks: Biotech stocks to watch as Phase III data and FDA decisions near
BNN Bloomberg
Biotech hot picks spotlight Xenon, United Therapeutics and Axsome as Phase III data and FDA decisions approach.
BNN Bloomberg spoke with Joe Thome, senior research analyst, biotech at TD Cowen, about his top picks in the sector and the milestones he believes could drive share performance this year.
Read the full transcript below:
ANDREW: Hot Picks: Our guest has a company working on advancing treatments for central nervous system disorders and neuropsychiatric conditions as his top selection. We’re joined now by Joe Thome, senior research analyst in biotech at TD Cowen. Thanks very much for joining us, Joe.
JOE: Thank you for having me.
ANDREW: I guess it’s a reminder to eat our bananas. This first company is working on potassium and its mechanism in the body. Tell us what catches your interest with Xenon.













